Rosen Law Firm & Nubank

Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that announced and filed a class action lawsuit against Nubank on behalf of investors who suffered damages.

Nubank: Nubank is the defendant in a class action lawsuit for allegedly making false and misleading statements regarding its compliance with Chinese regulatory requirements, leading to overstated financial results and potential penalties. Its stock price has declined significantly due to these allegations.

Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that has announced a class action lawsuit on behalf of purchasers of GeneDx Holdings Corporation common stock.

Nubank: Nubank is facing multiple class action lawsuits from investors alleging that its IPO documents were negligently prepared and that the company understated the risks of declining digital asset prices, leading to significant stock price drops after poor financial results.

Rosen Law Firm: The Rosen Law Firm encourages investors to join the Nubank class action lawsuit and seek qualified counsel.

Nubank: Nubank is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its financial performance and the impact of declining digital asset prices. Its stock price has fallen significantly following financial results announcements.

Rosen Law Firm: The Rosen Law Firm is actively investigating potential securities claims against Nubank and is preparing a class action lawsuit on behalf of affected shareholders.

Nubank: Nubank is also under investigation by Pomerantz LLP due to the resignation of its independent director and Audit Committee Chairman, which led to a drop in its ADS price.

Rosen Law Firm: Rosen Law Firm is a global investor rights law firm that announced an investigation into potential securities claims against Raytech Holding Limited, alleging misleading business information.

Nubank: Nubank was previously penalized by China in a similar crackdown, which is not directly related to the current event but provides context for China's regulatory actions.